1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Moldova Pharmaceuticals and Healthcare Report Q1 2017

Moldova Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 69 pages

Includes 3 FREE quarterly updates


BMI View:

Moldova’s pharmaceutical market presents very limited opportunities for multinational drugmakers, in comparison to its neighbours in Eastern Europe. The country’s small total market size and its reliance on out-of-pocket payments highlight the challenges it poses. Moreover, negative demographic trends and increasingly aggressive pricing strategies will limit growth prospects.

Headline Expenditure Projections



- Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.18bn (USD319mn) in 2016; 5.9% in local currency terms and 3.0% in US dollar terms. Forecast unchanged from previous quarter.

- Healthcare: MDL12.27bn (USD652mn) in 2015 to MDL13.13bn (USD678mn) in 2016; +7.0% in local currency terms and 4.1% in US dollar terms. Forecast unchanged from previous quarter. In our Q117 Pharmaceutical Risk/Reward Index (RRI) Moldova is ranked 21st out of the 20 markets in the Central and Eastern European (CEE) matrix, with its score of 36.5 unchanged from the previous quarter. Moldova scores well below the regional average score of 51.1 in Q117. The country’s overall Rewards score of 20.2 is easily the worst in the region and comfortably below the regional average (32.0) due to a particularly low Industry Rewards score.

Table Of Contents

Moldova Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Moldova 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Moldova 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Moldova 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Moldova 2014-2020) 27
Industry Risk Reward Index 28
Central And Eastern Europe Risk/Reward Index 28
Moldova Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 39
Pricing Regime 40
Reimbursement Regime 41
Market Overview 43
Healthcare Sector 44
Research And Development 47
Clinical Trials 47
Epidemiology 48
Competitive Landscape 51
Research-Based Industry 51
Table: Multinational Market Activity 52
Generic Drugmakers 52
Pharmaceutical Distribution 53
Pharmaceutical Retail Sector 55
Company Profile 56
Farmaco (Pharmaco) 56
Demographic Forecast 58
Table: Population Headline Indicators (Moldova 1990-2025) 59
Table: Key Population Ratios (Moldova 1990-2025) 59
Table: Urban/Rural Population and Life Expectancy (Moldova 1990-2025) 60
Table: Population By Age Group (Moldova 1990-2025) 60
Table: Population By Age Group % (Moldova 1990-2025) 61
Glossary 63
Methodology 65
Pharmaceutical Expenditure Forecast Model 65
Healthcare Expenditure Forecast Model 65
Notes On Methodology 66
Risk/Reward Index Methodology 67
Index Overview 68
Table: Pharmaceutical Risk/Reward Index Indicators 68
Indicator Weightings 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.